Nakornping Hospital is a hospital located in Chiang Mai, Thailand. It is the second largest hospital in Chiang Mai with an in-patient capacity of 742 beds as of 2022. It is now serving as the regional hospital of Chiang Mai province.

There are 742 beds in Nakornping Hospital.

During the past decade, Nakornping Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nakornping Hospital" #1 sponsor was "Institut de Recherche pour le Developpement" with 4 trials, followed by "The HIV Netherlands Australia Thailand Research Collaboration" with 3 trials sponsored, "PENTA Foundation" with 2 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials sponsored and "Arcus Biosciences, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nakornping Hospital" #1 collaborator was "Chiang Mai University" with 2 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials as a collaborator and "Ministry of Health, Thailand" with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Nakornping Hospital" are "HIV" (2 trials), "HIV Infection" (2 trials), "Pregnancy" (2 trials), "Acute Respiratory Failure" (1 trials) and "HIV-infected Children" (1 trials). Many other conditions were trialed in "Nakornping Hospital" in a lesser frequency.

Most popular intervention types in "Nakornping Hospital" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anti-HBV antiviral prophylaxis" (1 trials), "Carboplatin" (1 trials), "DTG" (1 trials), "DTG +DRV/r" (1 trials) and "Domvanalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nakornping Hospital" are 9 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Nakornping Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Nakornping Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nakornping Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".